ArticleJournal of managed care & specialty pharmacy2026
Clinical harm from failure to deploy personalized medicine for patients with metastatic non-small cell lung cancer.
Kristen Migliaccio-Walle et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.